The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues) Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate Year: 2007
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Cross sectional analysis of inflammatory mediators in exhaled breath condensate from COPD patients and healthy smoking controls Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and may serve as novel pro-inflammatory biomarkers in asthma and COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016
Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2012; 39: 59-66 Year: 2012
TOF-SIMS analysis of exhaled particles from patients with asthma and healthy controls Source: Eur Respir J 2011; 39: 59-66 Year: 2012
Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010